Cargando…

Future risk of cardiovascular disease risk factors and events in women after a hypertensive disorder of pregnancy

Hypertensive disorders of pregnancy (HDP), such as gestational hypertension and pre-eclampsia, affect up to 10% of all pregnancies. These women have on average a twofold higher risk to develop cardiovascular disease (CVD) later in life as compared with women with normotensive pregnancies. This incre...

Descripción completa

Detalles Bibliográficos
Autores principales: Benschop, Laura, Duvekot, Johannes J, Roeters van Lennep, Jeanine E
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6678044/
https://www.ncbi.nlm.nih.gov/pubmed/31175138
http://dx.doi.org/10.1136/heartjnl-2018-313453
_version_ 1783441007215378432
author Benschop, Laura
Duvekot, Johannes J
Roeters van Lennep, Jeanine E
author_facet Benschop, Laura
Duvekot, Johannes J
Roeters van Lennep, Jeanine E
author_sort Benschop, Laura
collection PubMed
description Hypertensive disorders of pregnancy (HDP), such as gestational hypertension and pre-eclampsia, affect up to 10% of all pregnancies. These women have on average a twofold higher risk to develop cardiovascular disease (CVD) later in life as compared with women with normotensive pregnancies. This increased risk might result from an underlying predisposition to CVD, HDP itself or a combination of both. After pregnancy women with HDP show an increased risk of classical cardiovascular risk factors including chronic hypertension, renal dysfunction, dyslipidemia, diabetes and subclinical atherosclerosis. The prevalence and onset of cardiovascular risk factors depends on the severity of the HDP and the coexistence of other pregnancy complications. At present, guidelines addressing postpartum cardiovascular risk assessment for women with HDP show a wide variation in their recommendations. This makes cardiovascular follow-up of women with a previous HDP confusing and non-coherent. Some guidelines advise to initiate cardiovascular follow-up (blood pressure, weight and lifestyle assessment) 6–8 weeks after pregnancy, whereas others recommend to start 6–12 months after pregnancy. Concurrent blood pressure monitoring, lipid and glucose assessment is recommended to be repeated annually to every 5 years until the age of 50 years when women will qualify for cardiovascular risk assessment according to all international cardiovascular prevention guidelines.
format Online
Article
Text
id pubmed-6678044
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher BMJ Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-66780442019-08-16 Future risk of cardiovascular disease risk factors and events in women after a hypertensive disorder of pregnancy Benschop, Laura Duvekot, Johannes J Roeters van Lennep, Jeanine E Heart Review Hypertensive disorders of pregnancy (HDP), such as gestational hypertension and pre-eclampsia, affect up to 10% of all pregnancies. These women have on average a twofold higher risk to develop cardiovascular disease (CVD) later in life as compared with women with normotensive pregnancies. This increased risk might result from an underlying predisposition to CVD, HDP itself or a combination of both. After pregnancy women with HDP show an increased risk of classical cardiovascular risk factors including chronic hypertension, renal dysfunction, dyslipidemia, diabetes and subclinical atherosclerosis. The prevalence and onset of cardiovascular risk factors depends on the severity of the HDP and the coexistence of other pregnancy complications. At present, guidelines addressing postpartum cardiovascular risk assessment for women with HDP show a wide variation in their recommendations. This makes cardiovascular follow-up of women with a previous HDP confusing and non-coherent. Some guidelines advise to initiate cardiovascular follow-up (blood pressure, weight and lifestyle assessment) 6–8 weeks after pregnancy, whereas others recommend to start 6–12 months after pregnancy. Concurrent blood pressure monitoring, lipid and glucose assessment is recommended to be repeated annually to every 5 years until the age of 50 years when women will qualify for cardiovascular risk assessment according to all international cardiovascular prevention guidelines. BMJ Publishing Group 2019-08 2019-06-07 /pmc/articles/PMC6678044/ /pubmed/31175138 http://dx.doi.org/10.1136/heartjnl-2018-313453 Text en © Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY. Published by BMJ. This is an open access article distributed in accordance with the Creative Commons Attribution 4.0 Unported (CC BY 4.0) license, which permits others to copy, redistribute, remix, transform and build upon this work for any purpose, provided the original work is properly cited, a link to the licence is given, and indication of whether changes were made. See: https://creativecommons.org/licenses/by/4.0/.
spellingShingle Review
Benschop, Laura
Duvekot, Johannes J
Roeters van Lennep, Jeanine E
Future risk of cardiovascular disease risk factors and events in women after a hypertensive disorder of pregnancy
title Future risk of cardiovascular disease risk factors and events in women after a hypertensive disorder of pregnancy
title_full Future risk of cardiovascular disease risk factors and events in women after a hypertensive disorder of pregnancy
title_fullStr Future risk of cardiovascular disease risk factors and events in women after a hypertensive disorder of pregnancy
title_full_unstemmed Future risk of cardiovascular disease risk factors and events in women after a hypertensive disorder of pregnancy
title_short Future risk of cardiovascular disease risk factors and events in women after a hypertensive disorder of pregnancy
title_sort future risk of cardiovascular disease risk factors and events in women after a hypertensive disorder of pregnancy
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6678044/
https://www.ncbi.nlm.nih.gov/pubmed/31175138
http://dx.doi.org/10.1136/heartjnl-2018-313453
work_keys_str_mv AT benschoplaura futureriskofcardiovasculardiseaseriskfactorsandeventsinwomenafterahypertensivedisorderofpregnancy
AT duvekotjohannesj futureriskofcardiovasculardiseaseriskfactorsandeventsinwomenafterahypertensivedisorderofpregnancy
AT roetersvanlennepjeaninee futureriskofcardiovasculardiseaseriskfactorsandeventsinwomenafterahypertensivedisorderofpregnancy